{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT01552707",
      "OrgStudyIdInfo": {
        "OrgStudyId": "XCEL-MT-10-02"
      },
      "Organization": {
        "OrgFullName": "Banc de Sang i Teixits",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Safety Study of Mesenchymal Stem Cells and Spinal Fusion",
      "OfficialTitle": "\"Ex Vivo\" Expanded Autologous Bone Marrow Mesenchymal Stem Cells Fixed in Allogenic Human Bone Tissue for Spinal Fusion in Spine Degenerative Disease"
    },
    "StatusModule": {
      "StatusVerifiedDate": "January 2020",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "July 19, 2012",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "May 3, 2018",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "October 21, 2019",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "March 8, 2012",
      "StudyFirstSubmitQCDate": "March 8, 2012",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "March 13, 2012",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "January 15, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 21, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Banc de Sang i Teixits",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "TFS Trial Form Support",
            "CollaboratorClass": "INDUSTRY"
          },
          {
            "CollaboratorName": "Ministerio de Sanidad, Servicios Sociales e Igualdad",
            "CollaboratorClass": "OTHER_GOV"
          },
          {
            "CollaboratorName": "Ministerio de Ciencia e Innovación, Spain",
            "CollaboratorClass": "OTHER_GOV"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The present prospective, randomized study, compares the spinal fusion obtained after instrumentation and the use of a biologic product (patient's mesenchymal cells obtained from his/her own bone marrow which will be fixed in human bone tissue form a donor), with the current procedure that consists in instrumented spinal fusion and the use of each patient's bone obtained from his/her iliac crest.\n\nThe working hypothesis proposes that the tissue engineering is a valid and useful technique to achieve bone regeneration, avoiding the need for obtaining patient's iliac crest and its associated morbidity.",
      "DetailedDescription": "Prospective, open-label, randomized, parallel, single-dose phase I-II clinical trial in which 62 patients affected with L4-L5 degenerative spondylolisthesis grade I-II according to Meyerding and/or with L4-L5 degenerative discopathy needing spinal fusion will enter the trial with the primary objective of assessing the feasibility and safety of \"ex-vivo\" expanded autologous mesenchymal stem cells fixed in allogenic bone tissue in spinal fusion. Secondary objectives are to assess the efficacy of the implantation by imaging (computerized helicoidal tomography and X-ray) and clinical questionnaires (pain by visual analogue scale, quality of life by SF-36 and Oswestry Disability Index).\n\nPatients will be randomized to one of the two treatment arms (instrumented spinal fusion and the tissue engineering product composed by \"ex-vivo\" expanded autologous mesenchymal stem cells fixed in allogenic bone tissue in spinal fusion or the standard treatment of instrumented spinal fusion and patient's bone iliac crest). Thereafter, patients will be followed for 12 months.\n\nImaging assessment will be done by an independent blinded radiologist."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Lumbar Spondylolisthesis Involving L4-L5, and/or",
          "Degenerative Discopathy Involving L4-L5"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Spondylolisthesis",
          "Degenerative discopathy",
          "Mesenchymal Stem Cells",
          "Bone marrow",
          "Tissue engineering",
          "Spinal fusion"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "69",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "XCEL-MT-OSTEO-ALPHA",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "\"ex-vivo\" expanded autologous mesenchymal stem cells fixed in allogenic bone tissue for spinal fusion",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: XCEL-MT-OSTEO-ALPHA"
              ]
            }
          },
          {
            "ArmGroupLabel": "Standard treatment",
            "ArmGroupType": "Sham Comparator",
            "ArmGroupDescription": "Instrumented spinal fusion together with patient's bone iliac crest.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: Standard treatment"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "XCEL-MT-OSTEO-ALPHA",
            "InterventionDescription": "Isolation and \"ex-vivo\" expansion of mesenchymal stem cells (MSC) obtained from each patient's bone marrow under GMP conditions at Xcelia, División de Terapias Avanzadas delBanc de Sang i Teixits. After expansion, MSCs are fixed in allogenic bone tissue and implanted in instrumented spinal fusion.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "XCEL-MT-OSTEO-ALPHA"
              ]
            }
          },
          {
            "InterventionType": "Procedure",
            "InterventionName": "Standard treatment",
            "InterventionDescription": "Instrumented spinal fusion together with patient's bone iliac crest",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Standard treatment"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "safety of XCEL-MT-OSTEO-ALPHA (tissue engineering product composed by \"ex-vivo\" expanded autologous mesenchymal stem cells fixed in allogenic bone tissue in spinal fusion)",
            "PrimaryOutcomeDescription": "Safety will be assessed by collecting adverse events throughout the experimental phase, which includes a follow-up of 12 months",
            "PrimaryOutcomeTimeFrame": "12 months"
          },
          {
            "PrimaryOutcomeMeasure": "Feasibility of XCEL-MT-OSTEO-ALPHA (composed by \"ex-vivo\" expanded autologous mesenchymal stem cells fixed in allogenic bone tissue in spinal fusion)",
            "PrimaryOutcomeDescription": "Feasibility will be measured by assessing the percentage of patients to which bone marrow puncture is made are thereafter treated and by checking the cascade of procedures to confirm the global process is viable.",
            "PrimaryOutcomeTimeFrame": "12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Efficacy spinal fusion by imaging procedures (X-Ray).",
            "SecondaryOutcomeDescription": "Spinal fusion will be assessed by spinal X-Ray",
            "SecondaryOutcomeTimeFrame": "3, 6 and 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Efficacy spinal fusion by imaging procedures (computerized helicoidal tomography)",
            "SecondaryOutcomeDescription": "Spinal fusion will be assessed by the presence of solid bonny bridges using computerized helicoidal tomography.",
            "SecondaryOutcomeTimeFrame": "6 and 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Clinical outcomes (VAS)",
            "SecondaryOutcomeDescription": "Pain measurement by visual analogue scale (VAS)",
            "SecondaryOutcomeTimeFrame": "7 days and at 3, 6 and 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Clinical outcomes (SF-36)",
            "SecondaryOutcomeDescription": "This clinical outcome will measure the quality of life by the self-reported quality of life questionnaire SF-36",
            "SecondaryOutcomeTimeFrame": "3, 6 and 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Clinical outcome (Oswestry Disability Index)",
            "SecondaryOutcomeDescription": "To assess the extent by which a person's functional level is restricted by disability by the Oswestry Disability Index",
            "SecondaryOutcomeTimeFrame": "3, 6 and 12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nL4-L5 degenerative spondylolisthesis grade I-II Meyerding isolated or associated to more than one level, and/or L4-L5 degenerative discopathy isolated or associated to more than one level.\n18 to 85 years of age (male and female)\nInformed Consent Form signed\nThe patient is able to understand the nature of the study\n\nExclusion Criteria:\n\nPrevious spine surgery\nL4 isthmic spondylolisthesis\nSmoker (more than 10 cigarettes a day)\nSystemic or local infection\nPatients treated with steroids (oral or systemic) within 3 months of entering the study, or treated with biphosphonates for more than 10 years\nPositive serology for HIV-1 or HIV-2, Hepatitis B (HBsAg), Hepatitis C (Anti-HCV-Ab) or Syphilis.\nPregnant woman or intended to become pregnant, or breath feeding\nNeoplasia within the previous 5 years, or without remission\nImmunosuppressive states (except diabetes mellitus. Treatment with therapies is allowed)\nSignificant abnormal laboratory tests that contraindicates the surgery.\nParticipation in another clinical trial or treated with an investigational medicinal product the previous 3 months\nOther pathologic conditions or circumstances that difficult participation in the study according to medical criteria\nThe patient does not accept to be followed-up for a period that could exceed the clinical trial length\nThe patient is legally dependent",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "85 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Joan Bagó, MD, PhD",
            "OverallOfficialAffiliation": "Hospital Vall d'Hebron",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Hospital Universitari Germans Trias i Pujol",
            "LocationCity": "Badalona",
            "LocationState": "Barcelona",
            "LocationZip": "08916",
            "LocationCountry": "Spain"
          },
          {
            "LocationFacility": "Parc de Salut Mar",
            "LocationCity": "Barcelona",
            "LocationZip": "08003",
            "LocationCountry": "Spain"
          },
          {
            "LocationFacility": "Hospital de la Santa Creu i Sant Pau",
            "LocationCity": "Barcelona",
            "LocationZip": "08025",
            "LocationCountry": "Spain"
          },
          {
            "LocationFacility": "Institut Universitari Dexeus (ICATME)",
            "LocationCity": "Barcelona",
            "LocationZip": "08028",
            "LocationCountry": "Spain"
          },
          {
            "LocationFacility": "Hospital Vall d'Hebron",
            "LocationCity": "Barcelona",
            "LocationZip": "08035",
            "LocationCountry": "Spain"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "25769789",
            "ReferenceType": "derived",
            "ReferenceCitation": "Vives J, Oliver-Vila I, Pla A. Quality compliance in the shift from cell transplantation to cell therapy in non-pharma environments. Cytotherapy. 2015 Aug;17(8):1009-14. doi: 10.1016/j.jcyt.2015.02.002. Epub 2015 Mar 10. Review."
          }
        ]
      },
      "SeeAlsoLinkList": {
        "SeeAlsoLink": [
          {
            "SeeAlsoLinkLabel": "Banc de Sang i Teixits. Xcelia, División de Terapias Avanzadas.",
            "SeeAlsoLinkURL": "http://www.bancsang.net"
          },
          {
            "SeeAlsoLinkLabel": "Institut Català de Traumatologia i Medicina de l'Esport (Institut Universitari Dexeus)",
            "SeeAlsoLinkURL": "http://www.icatme.com"
          },
          {
            "SeeAlsoLinkLabel": "Hospital Universitari Vall d'Hebron, Barcelona",
            "SeeAlsoLinkURL": "http://www.vhebron.net"
          },
          {
            "SeeAlsoLinkLabel": "Hospital Universitari Germans Trias i Pujol, Badalona",
            "SeeAlsoLinkURL": "http://www.gencat.cat/ics/germanstrias/"
          },
          {
            "SeeAlsoLinkLabel": "Hospital Parc de Salut Mar, Barcelona",
            "SeeAlsoLinkURL": "http://www.parcdesalutmar.cat"
          },
          {
            "SeeAlsoLinkLabel": "Hospital de la Santa Creu i Sant Pau, Barcelona",
            "SeeAlsoLinkURL": "http://www.santpau.es/"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000013168",
            "ConditionMeshTerm": "Spondylolisthesis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000013169",
            "ConditionAncestorTerm": "Spondylolysis"
          },
          {
            "ConditionAncestorId": "D000055009",
            "ConditionAncestorTerm": "Spondylosis"
          },
          {
            "ConditionAncestorId": "D000013122",
            "ConditionAncestorTerm": "Spinal Diseases"
          },
          {
            "ConditionAncestorId": "D000001847",
            "ConditionAncestorTerm": "Bone Diseases"
          },
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M15115",
            "ConditionBrowseLeafName": "Spondylolisthesis",
            "ConditionBrowseLeafAsFound": "Spondylolisthesis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M15116",
            "ConditionBrowseLeafName": "Spondylolysis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M27146",
            "ConditionBrowseLeafName": "Spondylosis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M15071",
            "ConditionBrowseLeafName": "Spinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4278",
            "ConditionBrowseLeafName": "Bone Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}